Skip to main content
. 2017 Jul 7;96(27):e7223. doi: 10.1097/MD.0000000000007223

Figure 3.

Figure 3

(A) Kaplan–Meier estimates of OS for East Asian patients and overall study population (data cutoff, September 16, 2013). (B) Kaplan–Meier estimates of updated OS for East Asian patients only (data cutoff, June 1, 2014). Dashed horizontal lines indicate median. Hazard ratios are based on unstratified Cox regression models with treatment as the only covariate, with values <1.00 favoring ENZA. CI = confidence interval, ENZA = enzalutamide, HR = hazard ratio, ITT = intent-to-treat, NYR = not yet reached, OS = overall survival.